ba g
nk
st in
Te urs
N
Table of Contents
Chapter 01: The Nursing Process and Drug Therapy........................................................................................... 3
Chapter 02: Pharmacologic Principles................................................................................................................. 9
Chapter 03: Lifespan Considerations ................................................................................................................ 15
Chapter 04: Cultural, Legal, and Ethical Considerations ................................................................................... 21
Chapter 05: Medication Errors: Preventing and Responding ............................................................................ 26
Chapter 06: Patient Education and Drug Therapy............................................................................................. 30
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements ................................................... 37
Chapter 08: Gene Therapy and Pharmacogenomics ........................................................................................ 43
Chapter 09: Photo Atlas of Drug Administration ............................................................................................. 49
Chapter 10: Analgesic Drugs ............................................................................................................................. 62
Chapter 11: General and Local Anesthetics ...................................................................................................... 71
Chapter 12: Central Nervous System Depressants and Muscle ................................................................ 75
Chapter 13: Central Nervous System Stimulants and Related .......................................................................... 80
Drugs Lilley: Pharmacology and the Nursing Process, 10th Edition .................................................................. 80
Chapter 14: Antiepileptic Drugs ....................................................................................................................... 84
Chapter 15: Antiparkinson Drugs ...................................................................................................................... 89
Chapter 16: Psychotherapeutic Drugs .............................................................................................................. 94
Chapter 17: Substance Use Disorder .............................................................................................................. 101
Chapter 18: Adrenergic Drugs ......................................................................................................................... 106
Chapter 19: Adrenergic-Blocking Drugs .......................................................................................................... 110
Chapter 20: Cholinergic Drugs ........................................................................................................................ 115
Chapter 21: Cholinergic-Blocking Drugs .......................................................................................................... 120
Chapter 22: Antihypertensive Drugs ............................................................................................................... 125
Chapter 23: Antianginal Drugs ........................................................................................................................ 132
Chapter 24: Heart Failure Drugs ..................................................................................................................... 141
Chapter 25: Antidysrhythmic Drugs................................................................................................................ 150
Chapter 26: Coagulation Modifier Drugs ........................................................................................................ 159
Chapter 27: Antilipemic Drugs ........................................................................................................................ 168
Chapter 28: Diuretic Drugs ............................................................................................................................. 176
Chapter 29: Fluids and Electrolytes ................................................................................................................ 183
Chapter 30: Pituitary Drugs ............................................................................................................................. 188
Chapter 31: Thyroid and Antithyroid Drugs .................................................................................................... 192
, ba g
nk
st in
Te urs
Chapter 32: Diabetes Drugs ............................................................................................................................ 197
N
Chapter 33: Adrenal Drugs .............................................................................................................................. 205
Chapter 34: Women’s Health Drugs................................................................................................................ 209
Chapter 35: Men’s Health Drugs ..................................................................................................................... 216
Chapter 36: Antihistamines, Decongestants, Antitussives, and ...................................................................... 220
Expectorants ................................................................................................................................................... 220
Chapter 37: Respiratory Drugs ........................................................................................................................ 226
Chapter 38: Antibiotics Part 1 ......................................................................................................................... 231
Chapter 40: Antiviral Drugs ............................................................................................................................. 242
Chapter 41: Antitubercular Drugs ................................................................................................................... 247
Chapter 42: Antifungal Drugs .......................................................................................................................... 251
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ................................................................. 256
Chapter 44: Anti-inflammatory and Antigout Drugs ....................................................................................... 260
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle-Specific ....................................... 265
Drugs ............................................................................................................................................................... 265
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific ................................................................... 271
Drugs and Miscellaneous Drugs ...................................................................................................................... 271
Chapter 47: Biologic Response–Modifying and Antirheumatic ...................................................................... 276
Chapter 48: Immunosuppressant Drugs ......................................................................................................... 280
Chapter 49: Immunizing Drugs........................................................................................................................ 285
Chapter 50: Acid-Controlling Drugs................................................................................................................. 289
Chapter 51: Bowel Disorder Drugs .................................................................................................................. 295
Chapter 52: Antiemetic and Antinausea Drugs .............................................................................................. 302
Chapter 53: Vitamins and Minerals................................................................................................................. 307
Chapter 54: Anemia Drugs .............................................................................................................................. 313
Chapter 55: Nutritional Supplements ............................................................................................................. 319
Chapter 56: Dermatologic Drugs..................................................................................................................... 323
Chapter 57: Ophthalmic Drugs ........................................................................................................................ 329
Chapter 58: Otic Drugs .................................................................................................................................... 333
, ba g
nk
st in
Te urs
N
Chapter 01: The Nursing Process and Drug Therapy
Lilley: Pharmacology and the Nursing Process, 10th Edition
MULTIPLE
CHOICE
1. The nurse is performing an assessment of a newly admitted patient. Which is an
example of subjective data?
a. Weight 155 pounds
b. Pulse 72 beats/minute
c. The patient reports that he uses the herbal product ginkgo
d. The patient‘s complete blood count results
ANS: C
Subjective data include information shared through the spoken word by any reliable
source, such as the patient. Objective data may be defined as any information gathered
through the senses or that which is seen, heard, felt, or smelled. A patient‘s pulse,
weight, and laboratory tests are all examples of objective data.
DIF: Cognitive Level: Understanding
(Comprehension) TOP: Nursing Process:
Assessment
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
2. When the nurse considers the timing of a drug dose, which factor is appropriate to
consider when deciding when to give a drug?
a. The patient‘s ability to swallow
b. The patient‘s height
c. The patient‘s last meal
d. The patient‘s allergies
ANS: C
The nurse must consider specific pharmacokinetic/pharmacodynamic drug properties that
may
be affected by the timing of the last meal. The patient‘s ability to swallow, height, and
allergies are not factors to consider regarding the timing of the drug‘s administration.
DIF: Cognitive Level: Understanding
(Comprehension) TOP: Nursing Process:
Assessment
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
3. The medication order reads, ―Give ondANSetron 4 mg, 30 minutes before beginning
chemotherapy to prevent nausea.‖ The nurse notes that the route is missing from the order.
What is the nurse‘s best action?
a. Give the medication intravenously because the patient might vomit.
b. Give the medication orally because the tablets are available in 4-mg doses.
c. Contact the prescriber to clarify the route of the medication ordered.
d. Hold the medication until the prescriber returns to make rounds.
ANS: C
A complete medication order includes the route of administration. If a medication order does
not include the route, the nurse must ask the prescriber to clarify it. The intravenous and oral
, ba g
nk
st in
Te urs
routes are not interchangeable. Holding the medication until the prescriber returns would
N
mean that the patient would not receive a needed medication.
DIF: Cognitive Level: Applying (Application)
TOP: Nursing Process: Implementation
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
nk
st in
Te urs
N
Table of Contents
Chapter 01: The Nursing Process and Drug Therapy........................................................................................... 3
Chapter 02: Pharmacologic Principles................................................................................................................. 9
Chapter 03: Lifespan Considerations ................................................................................................................ 15
Chapter 04: Cultural, Legal, and Ethical Considerations ................................................................................... 21
Chapter 05: Medication Errors: Preventing and Responding ............................................................................ 26
Chapter 06: Patient Education and Drug Therapy............................................................................................. 30
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements ................................................... 37
Chapter 08: Gene Therapy and Pharmacogenomics ........................................................................................ 43
Chapter 09: Photo Atlas of Drug Administration ............................................................................................. 49
Chapter 10: Analgesic Drugs ............................................................................................................................. 62
Chapter 11: General and Local Anesthetics ...................................................................................................... 71
Chapter 12: Central Nervous System Depressants and Muscle ................................................................ 75
Chapter 13: Central Nervous System Stimulants and Related .......................................................................... 80
Drugs Lilley: Pharmacology and the Nursing Process, 10th Edition .................................................................. 80
Chapter 14: Antiepileptic Drugs ....................................................................................................................... 84
Chapter 15: Antiparkinson Drugs ...................................................................................................................... 89
Chapter 16: Psychotherapeutic Drugs .............................................................................................................. 94
Chapter 17: Substance Use Disorder .............................................................................................................. 101
Chapter 18: Adrenergic Drugs ......................................................................................................................... 106
Chapter 19: Adrenergic-Blocking Drugs .......................................................................................................... 110
Chapter 20: Cholinergic Drugs ........................................................................................................................ 115
Chapter 21: Cholinergic-Blocking Drugs .......................................................................................................... 120
Chapter 22: Antihypertensive Drugs ............................................................................................................... 125
Chapter 23: Antianginal Drugs ........................................................................................................................ 132
Chapter 24: Heart Failure Drugs ..................................................................................................................... 141
Chapter 25: Antidysrhythmic Drugs................................................................................................................ 150
Chapter 26: Coagulation Modifier Drugs ........................................................................................................ 159
Chapter 27: Antilipemic Drugs ........................................................................................................................ 168
Chapter 28: Diuretic Drugs ............................................................................................................................. 176
Chapter 29: Fluids and Electrolytes ................................................................................................................ 183
Chapter 30: Pituitary Drugs ............................................................................................................................. 188
Chapter 31: Thyroid and Antithyroid Drugs .................................................................................................... 192
, ba g
nk
st in
Te urs
Chapter 32: Diabetes Drugs ............................................................................................................................ 197
N
Chapter 33: Adrenal Drugs .............................................................................................................................. 205
Chapter 34: Women’s Health Drugs................................................................................................................ 209
Chapter 35: Men’s Health Drugs ..................................................................................................................... 216
Chapter 36: Antihistamines, Decongestants, Antitussives, and ...................................................................... 220
Expectorants ................................................................................................................................................... 220
Chapter 37: Respiratory Drugs ........................................................................................................................ 226
Chapter 38: Antibiotics Part 1 ......................................................................................................................... 231
Chapter 40: Antiviral Drugs ............................................................................................................................. 242
Chapter 41: Antitubercular Drugs ................................................................................................................... 247
Chapter 42: Antifungal Drugs .......................................................................................................................... 251
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ................................................................. 256
Chapter 44: Anti-inflammatory and Antigout Drugs ....................................................................................... 260
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle-Specific ....................................... 265
Drugs ............................................................................................................................................................... 265
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific ................................................................... 271
Drugs and Miscellaneous Drugs ...................................................................................................................... 271
Chapter 47: Biologic Response–Modifying and Antirheumatic ...................................................................... 276
Chapter 48: Immunosuppressant Drugs ......................................................................................................... 280
Chapter 49: Immunizing Drugs........................................................................................................................ 285
Chapter 50: Acid-Controlling Drugs................................................................................................................. 289
Chapter 51: Bowel Disorder Drugs .................................................................................................................. 295
Chapter 52: Antiemetic and Antinausea Drugs .............................................................................................. 302
Chapter 53: Vitamins and Minerals................................................................................................................. 307
Chapter 54: Anemia Drugs .............................................................................................................................. 313
Chapter 55: Nutritional Supplements ............................................................................................................. 319
Chapter 56: Dermatologic Drugs..................................................................................................................... 323
Chapter 57: Ophthalmic Drugs ........................................................................................................................ 329
Chapter 58: Otic Drugs .................................................................................................................................... 333
, ba g
nk
st in
Te urs
N
Chapter 01: The Nursing Process and Drug Therapy
Lilley: Pharmacology and the Nursing Process, 10th Edition
MULTIPLE
CHOICE
1. The nurse is performing an assessment of a newly admitted patient. Which is an
example of subjective data?
a. Weight 155 pounds
b. Pulse 72 beats/minute
c. The patient reports that he uses the herbal product ginkgo
d. The patient‘s complete blood count results
ANS: C
Subjective data include information shared through the spoken word by any reliable
source, such as the patient. Objective data may be defined as any information gathered
through the senses or that which is seen, heard, felt, or smelled. A patient‘s pulse,
weight, and laboratory tests are all examples of objective data.
DIF: Cognitive Level: Understanding
(Comprehension) TOP: Nursing Process:
Assessment
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
2. When the nurse considers the timing of a drug dose, which factor is appropriate to
consider when deciding when to give a drug?
a. The patient‘s ability to swallow
b. The patient‘s height
c. The patient‘s last meal
d. The patient‘s allergies
ANS: C
The nurse must consider specific pharmacokinetic/pharmacodynamic drug properties that
may
be affected by the timing of the last meal. The patient‘s ability to swallow, height, and
allergies are not factors to consider regarding the timing of the drug‘s administration.
DIF: Cognitive Level: Understanding
(Comprehension) TOP: Nursing Process:
Assessment
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
3. The medication order reads, ―Give ondANSetron 4 mg, 30 minutes before beginning
chemotherapy to prevent nausea.‖ The nurse notes that the route is missing from the order.
What is the nurse‘s best action?
a. Give the medication intravenously because the patient might vomit.
b. Give the medication orally because the tablets are available in 4-mg doses.
c. Contact the prescriber to clarify the route of the medication ordered.
d. Hold the medication until the prescriber returns to make rounds.
ANS: C
A complete medication order includes the route of administration. If a medication order does
not include the route, the nurse must ask the prescriber to clarify it. The intravenous and oral
, ba g
nk
st in
Te urs
routes are not interchangeable. Holding the medication until the prescriber returns would
N
mean that the patient would not receive a needed medication.
DIF: Cognitive Level: Applying (Application)
TOP: Nursing Process: Implementation
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
